AJU-C714

N/A

Report date: 2025/04/23 20:01:04

Base Information

Drug NameAJU-C714
Drug Alias NameEzetimibe/RosuvastatinAJU-C714
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsCholesterol absorption inhibitorsNiemann-Pick C1-like protein 1 inhibitors
TargetsHMG-CoA reductaseNiemann-Pick C1-like protein 1
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Ezetimibe
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAju Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAju Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsDyslipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A